drugset / Trial / NCT01689649

A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy

NCT01689649

Phase 4 Completed 139 enrolled Janssen Research & Development, LLC
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this dose optimization study is to assess tolerability and efficacy of topiramate monotherapy in recently diagnosed patients with epilepsy who are treatment naive or have failed one anti-epileptic drug (AED) treatment in monotherapy.

Timeline

Start
2008-05-02
Primary completion
2010-01-19
Completion
2010-01-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 3 mg/kg Oral
Subject Topiramate Small molecule 100 mg Oral

Indications